Moxaclav Powder for Suspension

About Moxaclav 500 mg + 125 mg/5 ml Powder For Suspension

Moxaclav is a powder for suspension that, when mixed, provides 500 mg + 125 mg per 5 ml. It is a combination antibiotic made by Square Pharmaceuticals PLC and is used for certain bacterial infections.

There are 105 brands of Amoxicillin + Clavulanic Acid listed in Bangladesh. The lowest listed price is Moxilin CV 125 mg + 31.25 mg/5 ml Powder For Suspension at ৳ 1 per unit.

What is Moxaclav 500 mg + 125 mg/5 ml Powder For Suspension?

Moxaclav is an antibacterial medicine that combines amoxicillin with clavulanic acid. Amoxicillin is a penicillin-type antibiotic that acts against many bacteria, and clavulanic acid helps protect it from being broken down by certain bacterial enzymes. It comes as a powder that is mixed into a suspension before use. Because it is a prescription antibiotic, it should only be taken when a doctor has advised it for a confirmed or suspected bacterial infection. A pharmacist can show how to prepare the suspension and explain how to measure it.

Uses of Moxaclav

Moxaclav is used for short-term treatment of bacterial infections at several sites. These include upper respiratory tract infections such as tonsillitis, sinusitis and middle ear infection, and lower respiratory tract infections such as bronchitis and pneumonia. It is also used for genito-urinary tract infections such as cystitis and urethritis. It is not for viral illnesses such as the common cold, and a doctor decides whether it is suitable.

How to use Moxaclav

Moxaclav is supplied as a powder that must be mixed into a suspension before use, following the pharmacist's instructions. Measure the liquid with the spoon or device supplied, not a household spoon. Shake the bottle before each use. The doctor decides the amount and how long it is taken, and the full course should be completed as advised. Do not save leftover suspension for later use or share it with anyone else.

Side effects of Moxaclav

Side effects are uncommon and usually mild and short-lived. Diarrhoea, indigestion, nausea, vomiting and candidiasis have been reported, and taking the medicine at the start of meals may reduce stomach upset. Rashes sometimes occur. Rarely, more serious effects such as hepatitis, jaundice, severe skin reactions, angioedema and anaphylaxis have been reported. Call the doctor promptly if you notice a rash, swelling, breathing difficulty, yellowing of the skin or eyes, or severe or persistent diarrhoea.

Safety and precautions

Tell your doctor before use if you have ever had an allergic reaction to penicillin or other beta-lactam antibiotics, or if you have had liver or jaundice problems linked to this type of medicine. It should be used with care in people taking blood-thinning medicine or with severe liver disease, and the dose may need adjusting in kidney problems. Use in pregnancy is not recommended unless the doctor considers it essential, and small amounts may pass into breast milk. Ask your doctor first if you are pregnant, breastfeeding or have kidney or liver problems.

Frequently asked questions

What kind of medicine is Moxaclav and what is it used for?

Moxaclav is a combination antibiotic containing amoxicillin and clavulanic acid. It is used for short-term treatment of certain bacterial infections of the respiratory tract, ear, nose, throat and urinary tract. It does not treat viral infections such as the common cold, so a doctor decides if it is right for you.

How should I store Moxaclav?

Store the powder below 25°C, protected from light and moisture. Once mixed, keep the suspension in the refrigerator and do not freeze it. It should be used within the period the pharmacist advises, and any remaining suspension should be discarded afterwards. Ask your pharmacist if you are unsure.

What side effects should I watch for and when should I call the doctor?

Watch for diarrhoea, nausea, vomiting, indigestion or a rash. Call the doctor promptly if you notice swelling, breathing difficulty, yellowing of the skin or eyes, a severe skin reaction, or severe or persistent diarrhoea. Ask your doctor or pharmacist about anything that worries you.

Can I take Moxaclav with other medicines?

Some medicines can interact with it, including blood-thinning medicines, allopurinol and oral contraceptives, whose effectiveness may be reduced. Tell your doctor or pharmacist about all medicines you take, including ones bought without a prescription, before starting Moxaclav.

Indications

Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • ... Read more
Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • Genito-urinary tract infections e.g.cystitis,urethritis,pyelonephritis.
  • Skin and soft tissue infections.
  • Bone and joint infections e.g.osteomyelitis.
  • Other infections e.g.septic abortion,puerperal sepsis,intra-abdominal sepsis etc.

Pharmacology

Pharmacodynamic properties: Co-amoxiclav is an antibacterial combination consisting of the antibiotic Amoxicillin and the (3-lactamase inhibitor Clavulanic Acid. Amoxicillin has a broad spectrum of bactericidal activity against many Gram-positive & Gram-negative microorganisms but it is susceptible to degradation by (3-lactamases and therefore the spectrum of activity does not include microorganisms, which produce these enzymes. Clavulanic acid possesses the ability to inactivate a wide range of beta-lactamase enzymes commonly found in microorganisms resistant to penicillins and cephalosporins. Thus Clavulanic acid in this preparation protects Amoxicillin from degradation by (3-lactamase enzymes and effectively extends the antibiotic spectrum to embrace a wide range of microorganisms.

Pharmacokinetic properties: The pharmacokinetics of the two components of Co-amoxiclav is closely matched. Peak serum levels of both occur about one hour after oral administration. Absorption of Co-amoxiclav is optimized at the start of a meal. Both clavulanate and Amoxicillin have low levels of serum binding; about 70% remains free in the serum. Doubling the dosage of Co-amoxiclav approximately doubles the serum levels achieved.

Dosage & Administration

Adults and children over 12 years:

Tablet:
  • The usual adult dose is one 625 mg Tablet every 12 hours or one 375 mg Tablet every 8 hours.
  • For more severe infections and infections of the respiratory tract, the dose should be one 1 gm Tablet every 12 hours or one 625 mg Tablet every 8 hours.
Suspension:
  • Children 6-12 years: 2 teaspoonful every 8 hours.
  • Children 1-6years: 1 teaspoonful every 8 hours.
  • Children below 1 year: 25 mg/kg/day in divided doses every 8 hours, for example a 7.5 kg child would require 2 ml suspension t.i.d, Treatment should not be extended beyond 14 days without review.
Forte suspension:
  • The usual recommended daily dosage: 25/3.6 mg/kg/day in mild to moderate infections (upper respiratory tract infections e.g. recurrent tonsilitis, lower respiratory infections, and skin and soft tissue infections)।
  • For serious infections: 45/6.4 mg/kg/day for the treatment of more serious infections (upper respiratory tract infections, e.g. otitis media and sinusitis, lower respiratory infections e.g. bronchopneumonia, and urinary tract infections).
Children of 2 to 12 years:
Mild to moderate infections:
  • 25/3.6 mg/kg/day (Suspension)
  • 2-6 years (13-21 kg) 2.5 ml suspension b.i.d
  • 7-12years (22-40kg) 5 ml suspension b.i.d
Serious infections:
  • 45/6.4 mg/kg/day (Forte Suspension)
  • 2-6 years (13-21 kg) 5 ml suspension b.i.d
  • 7-12 years (22-40 kg) 10 ml suspension b.i.d
IV Injection

Adults-
  • Usually, 1.2 gm every 8 hours
  • Increased in more serious infections to 1.2 gm every 6 hours
  • For surgical prophylaxis: The usual dose is 1.2 gm at induction, for high risk procedures (eg. colorectal surgery) up to 2-3 gm may be given every 8 hours.
Children-
  • 0 to 3 months: 30 mg/kg every 8 hours. (every 12 hours in the perinatal period and in premature infants.
  • 3 months to 12 years: Usually 30 mg/kg every 8 hours increased in more serious infection to 30 mg/kg every 6 hours.

Interaction

Prolongation of bleeding time and prothrombin time have been reported in some patients receiving Co-amoxiclav. In common with other broad-spectrum antibiotics, Co-amoxiclav may reduce the efficacy of oral contraceptives and patients should be warned accordingly. Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of Co-amoxiclav and allopurinol.

Contraindications

History of Penicillin hypersensitivity. Attention should be paid to possible cross-sensitivity with other beta-lactam antibiotics e.g. cephalosporins. Also contraindicated for patients with a previous history of Co-amoxiclav or Penicillin-associated cholestatic jaundice.

Side Effects

Side effects, as with Amoxicillin, are uncommon and mainly of a mild and transitory nature. Diarrhoea, pseudomembranous colitis, indigestion, nausea, vomiting and candidiasis have been reported, if gastrointestinal side effects occur with oral therapy, that may be reduced by taking Co-amoxiclav at the start of meals. Hepatitis and cholestatic jaundice have been reported rarely but are usually reversible. Urticarial and erythematous rashes sometimes occur. Rarely erythema multiforme, Stevens-Johnson Syndrome and exfoliative dermatitis have been reported. In common with other beta-lactam antibiotics, angioedema and anaphylaxis have been reported.

Pregnancy & Lactation

Animal studies with orally and parenterally administered Co-amoxiclav have shown no teratogenic effect. The drug has been used orally in human pregnancy in a limited number of cases with no untoward effect; however, the use of Co-amoxiclav in pregnancy is not recommended unless considered essential by the physician. During lactation, trace quantities of Amoxicillin can be detected in breast milk.

Precautions & Warnings

Co-amoxiclav should be used with care in patients on anticoagulation therapy or with severe hepatic dysfunction. In patients with moderate or severe renal impairment, dosage should be adjusted. During the administration of a high dose of Co-amoxiclav adequate fluid intake and urinary output should be maintained to minimize the possibility of crystalluria.

Overdose Effects

Problems of overdose with Co-amoxiclav are unlikely to occur, if encountered gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Co-amoxiclav may be removed from the circulation by haemodialysis.

Storage Conditions

This should be stored below 25°C, protected from light and moisture. Once reconstituted suspension should be kept in the refrigerator (but not frozen) and should be usedby 7 days. Once reconstituted vial must be used within 20 minutes.

Alternative brands of Amoxicillin + Clavulanic Acid

Other brands with the same generic name, cheapest first.

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.